|
WO2006030847A1
|
|
Novel bicyclic pyrazole derivative
|
|
JP2006000121A
|
|
Recombinant dna virus vector for infection of animal cell
|
|
WO2005102369A1
|
|
Pharmaceutical preparation containing bacterial cell wall skeleton component
|
|
WO2005097891A1
|
|
Powder composition for use in forming artificial bone molding and platy molded object
|
|
WO2005093068A1
|
|
Novel protein and promoter
|
|
WO2005073374A1
|
|
Novel tumor antigen protein and utilization of the same
|
|
WO2005072717A1
|
|
Biguanide preparation for internal use
|
|
WO2005069188A1
|
|
Compound-protein interaction estimating system
|
|
JP2005194266A
|
|
Method for synthesizing indole and synthetic intermediate
|
|
WO2005035498A1
|
|
Use of nitrogenous bicyclic compound as feeding control agent
|
|
WO2005030773A1
|
|
Novel pyrazolopyrimidine derivatives
|
|
WO2005021792A1
|
|
Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
|
|
JP2005095166A
|
|
Disease marker of inflammatory bowel disease and utilization of the same
|
|
US2005158371A1
|
|
Novel external agent
|
|
JP2006045156A
|
|
Condensed pyrazole derivative
|
|
WO2005011669A1
|
|
Medicinal composition for percutaneous administration
|
|
JP2006036730A
|
|
New pyrrole derivative
|
|
WO2005009469A1
|
|
Novel drug for regulating blood sugar and method of screening the same
|
|
JP2004283183A
|
|
Recombinant adenovirus
|
|
WO2005007163A1
|
|
Antipruritic agent containing chroman compound as active ingredient
|
